Inventor · disambiguated record
Holger Beckmann
Also filed as: BECKMANN HOLGER
8 granted patents·2 pending applications·37 citations·filing 1997–2007
83Inventor score
Top patents by PatentIndex Score
10 records- 0176US7026122B2Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decayPTC THERAPEUTICS INC·Filed 2002·Granted Apr 11, 2006·5 cites·18 claims
- 0274US7449570B2Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseasesPTC THERAPEUTICS INC·Filed 2005·Granted Nov 11, 2008·2 cites·18 claims
- 0357US7763656B2Use of Acetylamino benzoic acid compounds for nonsense suppression and the treatment of diseasePTC THERAPEUTICS INC·Filed 2007·Granted Jul 27, 2010·0 cites·20 claims
- 0456US2006134681A1Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decayBECKMANN HOLGER·Filed 2005·Application pending·0 cites
- 0552US7247741B2Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of diseaseAMGEN INC·Filed 2005·Granted Jul 24, 2007·0 cites·9 claims
- 0650US6458538B1Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decayPTC THERAPEUTICS INC·Filed 1999·Granted Oct 1, 2002·13 cites·21 claims
- 0745US6306615B1Detection method for monitoring β tubulin isotype specific modificationTULARIK INC·Filed 1999·Granted Oct 23, 2001·6 cites·17 claims
- 0841US6555326B1Nuclear hormone receptor fluorescence polarization assayTULARIK INC·Filed 1997·Granted Apr 29, 2003·8 cites·18 claims
- 0937US2002106705A1Detection method for monitoring beta tubulin isotype specific modificationTULARIK INC·Filed 2001·Application pending·0 cites
- 1033US7101681B1Nuclear hormone receptor drug screensAMGEN INC·Filed 1998·Granted Sep 5, 2006·3 cites·29 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →